GlassScriptPhysician profile
Akash Makkar
NPI 1770612848
$318,130.29
in general payments reported to CMS, 2019-2025
42 companies · $70K in 2025
The $70K reported for 2025 was more than what 97% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $5,758 · 2021: $5,078 · 2022: $63K · 2023: $80K · 2024: $80K · 2025: $70K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $155K · Food and Beverage: $32K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Travel and Lodging: $19K · Education: $7.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $155,378.00 |
| Food and Beverage | $31,821.07 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,550.00 |
| Travel and Lodging | $18,608.28 |
| Education | $7.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $240,736.72 | 2019-2025 | Amplatzer Amulet, Jeti All In One Non-Sterile Kit, Mitraclip |
| Biosense Webster, INC. | $27,938.67 | 2019-2025 | Carto 3, Thermocool Sf, Thermocool Smarttouch |
| Boston Scientific Corporation | $26,078.59 | 2019-2025 | General - Brady, General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Medical Device Business Services, INC. | $9,375.00 | 2024 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,902.95 | 2019-2025 | Lifevest |
| Medtronic, INC. | $2,178.52 | 2021-2025 | Evera Mri Xt Dr Surescan, Symplicity G3, Micra |
| Medtronic Vascular, INC. | $1,722.92 | 2019-2020 | |
| Cvrx, INC. | $796.27 | 2022-2025 | Barostim Neo System |
| Abiomed | $707.83 | 2022-2025 | Impella |
| Impulse Dynamics (USA) INC. | $561.43 | 2022-2025 | Optimizer, Optimizer |
| Merck Sharp & Dohme LLC | $442.06 | 2021-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $416.91 | 2019-2025 | Camzyos |
| Biotronik INC. | $412.43 | 2019-2022 | |
| Atricure, INC. | $370.96 | 2019-2024 | |
| Aop Health US, LLC | $313.39 | 2025 | Rapiblyk |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $287.04 | 2019-2025 | Angiovac, Alphavac |
| Zoll Respicardia, INC. | $270.72 | 2023-2025 | Remede System |
| Novartis Pharmaceuticals Corporation | $256.26 | 2019-2023 | |
| Philips North America LLC | $251.32 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Cardiva Medical, INC. | $251.08 | 2021-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Volta Medical INC | $212.59 | 2023 | Vx1 |
| Kestra Medical Technology Services, INC. | $180.67 | 2023-2025 | Assure Wcd |
| Altathera Pharmaceuticals LLC | $158.34 | 2021-2025 | Sotalol Hydrochloride |
| Pfizer INC. | $138.93 | 2022-2024 | |
| Siemens Medical Solutions USA, INC. | $137.01 | 2020-2025 | Acuson Sc2000 Diagnostic Ultrasound System, Acuson Origin Diagnostic Ultrasound System |
| Sanofi-Aventis U.S. LLC | $134.44 | 2021-2024 | |
| Biom'Up France Sas | $130.05 | 2021 | |
| Penumbra, INC. | $129.44 | 2019 | |
| Edwards Lifesciences Corporation | $93.57 | 2024 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $86.36 | 2021-2025 | Farxiga |
| Bardy Diagnostics, INC. | $85.00 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $65.85 | 2020-2021 | |
| Amgen INC. | $60.16 | 2020-2023 | Repatha |
| Arineta, INC | $48.25 | 2023 | Spotlight |
| Cardiofocus, INC. | $39.76 | 2024 | Heartlight System |
| Teleflex LLC | $33.41 | 2024 | Quikclot |
| Davol INC. | $24.72 | 2025 | Channel Drain |
| Baxter Healthcare | $23.72 | 2024 | Perclot |
| Medicomp INC | $22.34 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.67 | 2022 | |
| Elutia, INC. | $18.63 | 2020 | |
| Alnylam Pharmaceuticals INC. | $16.31 | 2023 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$133.42 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akash Makkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.